Patent 10076546 was granted and assigned to Seres Therapeutics on September, 2018 by the United States Patent and Trademark Office.
Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.